Sign in
4

Changes in Ownership

NovoCure Ltd Filed Acc 0001562180-23-005014

Options or other derivatives

  • Director acquired 12,554 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Madden Martin J. Director 2023-06-07 Grant or award · Stock Option (Right to Buy) +12,554 12,554 D: show line 1 in the form
Loading xslF345X04/primarydocument.xml…